Those who think that Medicare isn’t restricting on new therapies, think again. By cutting reimbursement to new cancer drugs, they are essentially preventing hospitals from giving it:
. . . the companies say Medicare’s data must be inaccurate and that no hospital will offer the drugs to Medicare patients if it is losing $10,000 or more on each treatment.
Patients lose.
Get free updates delivered free to your inbox.
Search thousands of physician, PA, NP, and CRNA jobs now.
Comments are moderated before they are published. Please read the comment policy.
